GAZYVA

Google image searchProduct monograph

Active ingredient

obinutuzumab, 25 MG/ML

DIN: 02434806

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE DOSE VIAL

Schedule: Prescription / Schedule D

Company: HOFFMANN-LA ROCHE LIMITED

Date: 28-NOV-2014

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FA — CD20 (Clusters of Differentiation 20) inhibitors (ATC, ATC/DDD)
• L01FA03 — OBINUTUZUMAB (ATC/DDD)

External Links for Gazyva

Search on Google

• Gazyva side effects
• Gazyva dosage
• obinutuzumab side effects
• obinutuzumab dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find gazyva photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.